Clinical Trial Update: Comparison of Dual-mode ER:YAG Laser in Patients With Long Keloid/Hypertrophic Scars [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a dual-mode ER:YAG laser for long keloids and hypertrophic scars has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Scar
• Keloid

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Keloid, Hypertrophic Scars | Phase 2 | Status: WITHDRAWN